Urothelial carcinoma is the most common bladder cancer, with stage 1 indicating early-stage disease confined to the bladder lining. Diagnosis involves urinalysis, cystoscopy, TURBT, and imaging to ...
Long-term outcomes of pembrolizumab (pembro) in combination with gemcitabine (gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial ...
UGN-102 shows a 79.6% complete response rate in recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer. UGN-102 offers a non-surgical alternative, avoiding cystoscopy and anesthesia, ...
More than 250,000 people undergo a transurethral procedure each year in the U.S., and up to 10% of those people will experience a postoperative infection. But researchers have discovered an indicator ...
Department of Urology, All India Institute of Medical Sciences (AIIMS) Jammu, has commenced advanced endourological services, ...
Robotic Surgery Offers Durable Prostate Cancer Control Transurethral resection of bladder tumor can cause cancer cells to be infused into the bloodstream. In a “proof of concept” study, researchers ...
or on the link below. Non–muscle-invasive bladder cancer (NMIBC) comprises 75% of newly diagnosed bladder cancer and poses significant clinical challenges because of high recurrence and progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback